Cargando…
Early Antiretroviral Therapy During Primary HIV-1 Infection Results in a Transient Reduction of the Viral Setpoint upon Treatment Interruption
BACKGROUND: Long-term benefits of combination antiretroviral therapy (cART) initiation during primary HIV-1 infection are debated. METHODS: The evolution of plasma HIV-RNA (432 measurements) and cell-associated HIV-DNA (325 measurements) after cessation of cART (median exposure 18 months) was descri...
Autores principales: | von Wyl, Viktor, Gianella, Sara, Fischer, Marek, Niederoest, Barbara, Kuster, Herbert, Battegay, Manuel, Bernasconi, Enos, Cavassini, Matthias, Rauch, Andri, Hirschel, Bernard, Vernazza, Pietro, Weber, Rainer, Joos, Beda, Günthard, Huldrych F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216952/ https://www.ncbi.nlm.nih.gov/pubmed/22102898 http://dx.doi.org/10.1371/journal.pone.0027463 |
Ejemplares similares
-
Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection
por: Kouyos, Roger D., et al.
Publicado: (2011) -
Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T-Cell Decline, and Per-Parasite Pathogenicity
por: Bertels, Frederic, et al.
Publicado: (2018) -
A Comparison of Initial Antiretroviral Therapy in the Swiss HIV Cohort Study and the Recommendations of the International AIDS Society-USA
por: Wandeler, Gilles, et al.
Publicado: (2011) -
The Individualized Genetic Barrier Predicts Treatment Response in a Large Cohort of HIV-1 Infected Patients
por: Beerenwinkel, Niko, et al.
Publicado: (2013) -
Adverse events of raltegravir and dolutegravir
por: Elzi, Luigia, et al.
Publicado: (2017)